| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 57.566 | 62 |
| GSM780708 | Untreated after 4 days (C2_1) | 59.6092 | 64 |
| GSM780709 | Untreated after 4 days (C3_1) | 60.9803 | 65 |
| GSM780719 | Untreated after 4 days (C1_2) | 63.0528 | 66 |
| GSM780720 | Untreated after 4 days (C2_2) | 41.8332 | 12 |
| GSM780721 | Untreated after 4 days (C3_2) | 53.116 | 56 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 50.3391 | 50 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.4538 | 34 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 52.9929 | 56 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 40.6903 | 8 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 41.0811 | 10 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.1365 | 37 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 49.5819 | 47 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 52.3482 | 55 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 57.5618 | 62 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 51.2651 | 52 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 43.2808 | 19 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 52.1484 | 54 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 52.2866 | 55 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 55.4315 | 60 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 51.3025 | 52 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.0268 | 37 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 53.7731 | 58 |